[Form 4] Viavi Solutions Inc. Insider Trading Activity

Rhea-AI Filing Summary

Insider sale under pre-arranged plan: Kevin Christopher Siebert, Senior Vice President, General Counsel and Secretary of Viavi Solutions Inc. (VIAV), reported a sale of 13,115 shares of Viavi common stock on 08/29/2025 executed under a Rule 10b5-1 trading plan dated September 10, 2024. The weighted average sale price was $11.18 per share, with execution prices ranging from $11.10 to $11.27. After the reported transactions, Mr. Siebert beneficially owned 71,159 shares. The Form 4 was signed by an attorney-in-fact on 09/02/2025.

Positive

• Sale executed under a Rule 10b5-1 plan, indicating a pre-arranged, programmatic trade structure
• Weighted average sale price disclosed ($11.18) with price range ($11.10–$11.27) and offer to provide full execution details on request
• Post-transaction beneficial ownership disclosed (71,159 shares), providing transparency

Negative

• Insider reduced holdings by 13,115 shares, which may be viewed negatively by some investors
• No information on percentage ownership or total outstanding shares is provided in the filing, limiting context about scale of the sale

Insights

Securities Analyst

TL;DR: Officer sold shares under a Rule 10b5-1 plan; sale reduces insider stake but follows an established trading plan.

The filing documents a non-derivative disposition of 13,115 shares at a weighted average price of $11.18 executed on 08/29/2025. The sale was made pursuant to a Rule 10b5-1 plan dated 09/10/2024, which provides an affirmative defense against insider trading claims when properly adopted and executed. The reporting person retains 71,159 shares after the transactions, which remains publicly disclosed. For investors, the key observable facts are the size of the sale, the stated plan, and the post-sale beneficial ownership; no options or derivative transactions are reported.

Corporate Governance Expert

TL;DR: The transaction appears procedurally compliant and clearly disclosed under Section 16 rules.

The Form 4 indicates the officer used a Rule 10b5-1 stock trading plan to effect sales, and the explanatory note discloses price ranges and weighted average sale price. The filing includes an attorney-in-fact signature, consistent with permitted filing procedures. There is no disclosure of amendments or additional transactions beyond the single reported disposition. From a governance perspective, the document provides the necessary transparency required by Section 16 filings.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Siebert Kevin Christopher

(Last) (First) (Middle)

C/O VIAVI SOLUTIONS INC.

1445 SOUTH SPECTRUM BLVD, SUITE 102

(Street)

CHANDLER AZ 85286

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
VIAVI SOLUTIONS INC. [ VIAV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP Gen. Counsel & Secretary

3. Date of Earliest Transaction (Month/Day/Year)
09/02/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/29/2025		S(1)		13,115	D	$11.18(2)	71,159	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares were sold pursuant to a Rule 10b5-1 Stock Trading Plan dated September 10, 2024.

2. This transaction was executed in multiple trades at prices ranging from $11.10 to $11.27. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

	/s/ Donna T. Rossi, attorney-in-fact	09/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did VIAV insider Kevin Siebert sell and when?

He sold 13,115 shares of Viavi common stock on 08/29/2025, reported on Form 4 filed 09/02/2025.

At what price were the VIAV shares sold by the insider?

The weighted average sale price was $11.18 per share, with execution prices ranging from $11.10 to $11.27.

Was the insider sale of VIAV shares pre-planned?

Yes. The sale was made pursuant to a Rule 10b5-1 trading plan dated September 10, 2024.

How many Viavi shares does the reporting person own after the sale?

71,159 shares of common stock are reported as beneficially owned following the transaction.

Who signed the Form 4 for the reporting person?

The Form 4 was signed by /s/ Donna T. Rossi, attorney-in-fact on 09/02/2025.